[Fatty acids in diabetes mellitus].

Area of Science:

• Biochemistry
• Metabolic Disorders
• Cardiovascular Research

Background:

• Diabetes mellitus type II is associated with metabolic dysregulation.
• Altered lipid profiles are implicated in the pathogenesis of diabetic vascular complications.
• Fatty acids play a crucial role in cellular function and disease development.

Purpose of the Study:

• To investigate the levels of saturated and unsaturated fatty acids in the serum and high-density lipoproteins (HDL) of patients with type II diabetes mellitus.
• To determine if diabetes compensation affects these fatty acid profiles.
• To explore the potential link between altered fatty acid levels and atherogenesis in diabetes.

Main Methods:

• Serum and HDL fatty acid analysis in 38 patients with type II diabetes and 20 healthy controls.
• Comparison of fatty acid profiles in decompensated versus compensated diabetes.
• Quantification of total saturated and unsaturated fatty acids, including palmitic, stearic, oleic, and arachidonic acids.

Main Results:

• Decompensated diabetes showed increased serum and HDL saturated fatty acids with decreased unsaturated fatty acids.
• Specific fatty acids affected: increased palmitic and stearic acids, decreased oleic and arachidonic acids in decompensated diabetes.
• Diabetes compensation normalized the ratio of saturated to unsaturated fatty acids and individual fatty acid levels.

Conclusions:

• Type II diabetes mellitus significantly alters serum and HDL fatty acid composition.
• Normalization of fatty acid profiles is achievable with diabetes compensation.
• Changes in fatty acid levels during diabetes may contribute to the development of vascular lesions and atherogenesis.